Stryker price target raised to $405 from $348 at Roth MKM

Roth MKM raised the firm’s price target on Stryker to $405 from $348 and keeps a Buy rating on the shares. The analyst says the company’s Q1 earnings upside being “top-line driven” while noting that Stryker continues to “fire on all cylinders”. The company’s management has also expressed continued optimism on sustained top-line strength thanks to strong pipeline investment while remaining on track to regain 200bp of margin improvement by the end of 2025, the analyst tells investors in a research note.